ArticleToxicology reports2026
Metabolic disruption associated with e-cigarette vaping and secondhand exposure: Urinary metabolomics evidence from a Thai population.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing use of electronic cigarettes (e-cigarettes) has raised concerns regarding potential health effects associated with both direct use and secondhand exposure to e-cigarette aerosols. However, human evidence describing systemic metabolic alterations related to these exposures remains limited. In this study, metabolomics was applied to compare urinary metabolic profiles among active e-cigarette users, individuals exposed to secondhand e-cigarette aerosols, and unexposed control participants. Multivariate analyses were performed to identify exposure-related metabolic signatures, followed by pathway enrichment and evaluation of candidate biomarkers. Distinct metabolic differences were observed across exposure groups. Direct e-cigarette use was associated with alterations in amino acid metabolism, mitochondrial energy pathways, and redox-related processes, with glutathione metabolism identified as a key associated pathway and oxidized glutathione highlighted as a candidate urinary biomarker of redox-related metabolic alterations. Secondhand exposure was primarily associated with alterations in alanine, aspartate, and glutamate metabolism, with L-glutamic acid demonstrating discriminatory performance as a candidate metabolite associated with metabolic differences related to secondhand e-cigarette aerosol exposure. Comparative pathway analyses suggested that direct e-cigarette use was associated with more extensive metabolic alterations than secondhand exposure, particularly in pathways linking glutamine-glutamate metabolism, the tricarboxylic acid cycle, and glutathione metabolism, suggesting a possible graded biological response to aerosol exposure. In addition, nicotine metabolism-related metabolites and e-liquid constituents, including propylene glycol, glycerol, and cotinine
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.